ArticleACS omega2025
Eco-Friendly Approaches in Oncology: Developing Holmium (
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Disphosphate based hydrogel microspheres for targeted transarterial radioembolization and chemoembolization therapies.Journal of advanced research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Using recycled materials is increasingly recognized as a crucial strategy in today's global context. The production of glass on a global scale, estimated at approximately 209 million tons annually, underscores the urgent necessity to identify alternative applications for this material. In this milieu, the adoption of recycled glass for applications conducive to health emerges as a significant opportunity, offering dual advantages: mitigating the global surplus of glass and enhancing public health outcomes. In the realm of diseases, oncology, and hepatocellular carcinoma stand out due to their extensive costs and detrimental impact on health. Consequently, this research has been directed toward developing, comprehensively characterization, and in vivo assessment of Ho (Ho-166) holmium-166 doped glass microspheres derived from recycled glass. The findings confirmed the successful formation of these microspheres, marked by a high degree of holmium doping. Moreover, the studies revealed a significant accumulation of the microspheres in the liver, alongside a lack of toxicological effects. Collectively, these results strongly support the potential of recycled glass as a valuable resource for fabricating holmium-doped glass microspheres, offering a promising avenue for liver cancer treatment.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.